ReviewHeart failure reviews2025
Demographic disparities in heart failure with preserved ejection fraction.
Review in Heart failure reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review comprehensively examines the complex influence of demographic factors on heart failure with preserved ejection fraction (HFpEF), an increasingly common clinical syndrome. We examine the impact of age, sex, race/ethnicity, and socioeconomic status on HFpEF, investigating how these factors contribute to disparities in prevalence, risk profiles, diagnostic challenges, treatment responses, and clinical outcomes. Key findings highlight the significant role of age, with HFpEF incidence rising with advancing age advances and distinct pathophysiological mechanisms noted across age groups. Gender disparities are also evident, with women showing a greater predisposition to HFpEF, possibly linked to physiological differences and sex-specific risk factors. The review also addresses racial and ethnic disparities, recognizing the limitations in current data while stressing the need for more inclusive research to comprehend the specific impact of race on HFpEF. Finally, the essential role of socioeconomic factors is examined, illustrating how income and education can affect access to care, treatment adherence, and overall outcomes. Furthermore, we aim to underscore the importance of a holistic approach to HFpEF, recognizing the interplay of demographic factors in shaping disease trajectory and patient experiences. By synthesizing current evidence and identifying key knowledge gaps, we aim to inform future research directions, promote equitable healthcare delivery, and ultimately improve the lives of individuals affected by this complex condition.
Indexed as
Identifiers
40676403What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.